HIV-associated Burkitt's lymphoma

By Aissata Tolo and Catherine Traoré

The epidemiology of HIV-associated Burkitt's lymphoma remains poorly understood in Africa, despite the continent being the birthplace of endemic Burkitt's lymphoma. This 14-year study focused on patients aged 18 years and over who had Burkitt's lymphoma and were HIV-positive. Of 50 adult patients admitted to hospital for Burkitt's lymphoma, HIV testing was carried out on 21 patients, 11 of whom tested positive, representing a prevalence of 52.4 per cent. The mean age was 33.9 years 9.3; there was a predominance of female patients, with a sex ratio of 0.6. An abdominal-pelvic mass was the main reason for hospitalisation. The combination of ovarian and breast involvement was the most common. Murphy stage III was the most common. HIV-1 was common, associated with a history of opportunistic infection. Severe immunosuppression was common, with a CD4 count below 200 cells/mm3. The case-fatality rate was 72.7 per cent. Drug-related toxicity was the main cause of death.

• Format: Paperback
• Language: English
• ISBN: 6630284321
• ISBN13: 9786630284324
• Release Date: July 2026
• Publisher: Our Knowledge Publishing
• Length: 52 Pages
• Weight: 0.18 lbs.
• Dimensions: 0.1" x 6.0" x 9.0"